Park Medi World shares opened at ₹158.80 on the NSE, a discount of ₹3.2 or 2 per cent from the issue price of ₹162
Corona Remedies shares opened at ₹1,470 on the NSE, a premium of ₹408 or 38 per cent from the issue price of ₹1,062
Modi Naturals aims to acquire brands in ready-to-eat and healthy snacks as it grows its FMCG portfolio, saying its NSE listing will improve visibility, liquidity and investor reach
Applicants can check their Wakefit Innovations IPO allotment status on the official websites of NSE and BSE, or the registrar Kfin Technologies
Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability
Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price
Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer
The BSE Sensex tumbled 803 points in the intraday to hit a low of 84,909, and the NSE Nifty50 also slipped below the 26,000 mark in the intraday to hit a low of 25,902.95
Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5
Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies
Indus Towers has consistently traded above all its significant EMAs, reflecting a positive market sentiment, and Policybazaar has also demonstrated a consistent performance
JM Financial has set a target price of ₹1,215 per share, implying an upside potential of 21 per cent
Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.
Vidya Wires IPO will open for subscription on Wednesday, December 3, 2025, and close on Friday, December 5, 2025
Domestic brokerage Nuvama Institutional Equities expects the FMCG major Emami to witness a double-digit revenue growth in H2FY26
HDFC Securities expects Eureka Forbes to deliver strong growth over FY25-28, with revenue, Ebitda, and profit rising at a CAGR of 14 per cent, 23 per cent, and 27 per cent, respectively
Sudeep Pharma's unlisted shares were trading at ₹679, reflecting a grey market premium of ₹86 or 14.5 per cent above the upper end of the price band of ₹563 to ₹593
SBI Securities expects Pricol's revenue, Ebitda, and PAT to grow at 31 per cent, 33 per cent, and 36 per cent CAGR, respectively, over FY25-27
Tenneco Clean Air stock listed at ₹505 on the NSE, opening with a 27 per cent premium over the issue price of ₹397 per share
PhysicsWallah stock made a solid debut on Dalal Street, listing at ₹145 on the NSE, a 33 per cent premium compared to the issue price of ₹109